Skip to main content

Advertising Disclaimer »

Main menu

  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • AAP Policy
    • Topic/Program Collections
    • Policy
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effect on Pediatric Health
    • More Collections...
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Alerts
    • Table of Contents
    • Insights
  • AAP Career Center
  • Subscribe
  • Other Publications
    • American Academy of Pediatrics

User menu

  • Log in
  • My Cart

Search

  • Advanced search
American Academy of Pediatrics

AAP Gateway

Advanced Search

AAP Logo

  • Log in
  • My Cart
  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • AAP Policy
    • Topic/Program Collections
    • Policy
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effect on Pediatric Health
    • More Collections...
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Alerts
    • Table of Contents
    • Insights
  • AAP Career Center
  • Subscribe

Journals Blog

  • Visit AAP News on Facebook
  • Follow AAP News on Twitter

How Safe Is Propranolol for Treatment of Infant Hemangiomas? A Systematic Review Does More Than Just Skin the Surface

Dr Lewis First, MD,MA, Editor-in-Chief, Pediatrics
September 29, 2016

The use of propranolol and timolol for treatment of infantile hemangiomas is not new news to most of us, based on the many case reports and subsequent clinical trials that herald its success as a treatment agent for this problem. What we also see on occasion are case reports and study results that suggest there can be some serious and not so serious adverse effects of using propranolol in these patients. So just what are these side effects and how common are they?  Leaute-Labreze et al ( 10.1542/peds.2016-0353) decided to address these questions by performing a systematic review to better determine the safety profile of propranolol when used for this purpose in a review article being released this week.  

The authors looked for studies that included at least ten treated patients and then reported on at least one adverse event.  More than 80 studies met review criteria involving more than 5800 infants treated and more than 1999 adverse events. Just what those events were (and how severe) forms the basis of the review.  The benefits of reading this review are that you will be more apt to prescreen infants who might be identified in advance as being at risk for an adverse side effect of the drug rather than increase their risk of having an adverse event by simply using it.  

This study makes its mark on when to use and not use propranolol or another beta-blocker to treat infant hemangiomas—and will hopefully prevent you from turning red from an adverse event occurring that you might have prevented by not using the drug in certain clinical situations.  Read this study and learn more.

Further Reading
  • Initial Experience With Propranolol Treatment of Lymphatic Anomalies: A Case Series
  • Rebound Growth of Infantile Hemangiomas After Propranolol Therapy
  • Pediatrics on Facebook
  • Pediatrics on Twitter
Copyright © 2016 American Academy of Pediatrics

Advertising Disclaimer »

Download PDF
Share
How Safe Is Propranolol for Treatment of Infant Hemangiomas? A Systematic Review Does More Than Just Skin the Surface
Dr Lewis First, MD,MA
September 29, 2016
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Email Blog Post

Thank you for your interest in spreading the word on American Academy of Pediatrics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
How Safe Is Propranolol for Treatment of Infant Hemangiomas? A Systematic Review Does More Than Just Skin the Surface
(Your Name) has sent you a message from American Academy of Pediatrics
(Your Name) thought you would like to see the American Academy of Pediatrics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Digital Edition Current Issue
  • Latest Daily News
  • Archives
  • Collections
  • Columns
  • Advertising
  • Subscribe to AAP News Magazine
  • Terms of Use
  • Privacy Statement
  • FAQ
  • Contact Us
  • 2021 AAP Journals Catalog
  • Pediatrics
  • Pediatrics in Review
  • Hospital Pediatrics
  • NeoReviews
  • AAP Grand Rounds
  • AAP Career Center
  • shopAAP
  • AAP.org
  • AAP News
  • Visit AAP News on Facebook
  • Follow AAP News on Twitter
American Academy of Pediatrics

© 2021 American Academy of Pediatrics